Adenosine a2a receptor antagonists for the treatment of extra-pyramidal syndrome and other movement disorders

A technology of receptor antagonist and extrapyramidal system, applied in the field of adenosine A2a receptor antagonist

Inactive Publication Date: 2008-11-26
SCHERING AG
View PDF9 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

EPS is more common with typical antipsychotics but has also been reported with atypical agents

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Adenosine a2a receptor antagonists for the treatment of extra-pyramidal syndrome and other movement disorders
  • Adenosine a2a receptor antagonists for the treatment of extra-pyramidal syndrome and other movement disorders
  • Adenosine a2a receptor antagonists for the treatment of extra-pyramidal syndrome and other movement disorders

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

There is disclosed a method for the treatment or prevention of Extra Pyramidal syndrome (EPS), dystonia, restless legs syndrome (RLS) or periodic leg movement in sleep (PLMS) comprising the administration of an adenosine A2a receptor antagonist, alone or in combination with other agents useful for treating EPS, dystonia, RLS or PLMS.

Description

field of invention The present invention relates to adenosine A 2a Use of receptor antagonists for the treatment of a variety of neurological syndromes involving the extrapyramidal motor system (ie, extrapyramidal syndromes) that occur after short-term and long-term use of almost all antipsychotic drugs. The present invention also relates to adenosine A 2a Use of receptor antagonists for the treatment of other abnormal movement disorders such as restless legs syndrome (RLS) and periodic limb movements during sleep (PLMS). Background of the invention Extrapyramidal syndrome (EPS) is a collective term for a series of adverse neurologic effects associated with the use of antipsychotic drugs. There are six distinct classes of EPS-associated neurological syndromes, four of which - dystonia, akathisia, pseudoparkinsonism (parkinsonism) and tardive dyskinesia - in patients receiving antipsychotic medication Especially prevalent among patients. Dystonia is painful spasm of muscl...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/52A61P21/00A61K31/519A61K45/06
CPCA61K31/52A61K31/519A61K45/06A61P21/00A61P25/02A61P25/08A61P25/14A61P25/16A61P25/20A61P43/00A61K2300/00
Inventor M·葛兹拉克J·C·杭特A·庞德G·维提
Owner SCHERING AG
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products